Meridian Financial Partners LLC Vertex Pharmaceuticals Inc Transaction History

Meridian Financial Partners LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	BUY	$234.96 - $292.55 $704 - $877	3 Added 0.08%	3,534 $1.01 Million
Q1 2022 May 02, 2022	BUY	$221.42 - $260.97 $29,448 - $34,709	133 Added 3.91%	3,531 $921,000
Q4 2021 Jan 27, 2022	BUY	$177.01 - $223.45 $90,098 - $113,736	509 Added 17.62%	3,398 $784,000
Q3 2021 Oct 25, 2021	BUY	$181.39 - $202.99 $11,246 - $12,585	62 Added 2.19%	2,889 $521,000
Q2 2021 Jul 21, 2021	BUY	$187.49 - $221.1 $21,186 - $24,984	113 Added 4.16%	2,827 $556,000
Q1 2021 Apr 21, 2021	BUY	$207.02 - $241.31 $37,884 - $44,159	183 Added 7.23%	2,714 $598,000
Q4 2020 Jan 21, 2021	BUY	$207.01 - $276.09 $523,942 - $698,783	2,531 New	2,531 $599,000

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Meridian Financial Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Meridian Financial Partners LLC with notifications on news.